Healthcare provider profile · identity verified

Daniel J Stauffer, MD

Family Practice · QUAKERTOWN, PA · NPI 1124087325

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	575	135
Atorvastatin Calcium	Atorvastatin Calcium	388	94
Amlodipine Besylate	Amlodipine Besylate	352	85
Lisinopril	Lisinopril	264	66
Simvastatin	Simvastatin	259	66
Metformin Hcl	Metformin Hcl	248	62
Metoprolol Succinate	Metoprolol Succinate	236	52
Pantoprazole Sodium	Pantoprazole Sodium	234	52
Omeprazole	Omeprazole	224	49
Metoprolol Tartrate	Metoprolol Tartrate	182	49
Glimepiride	Glimepiride	176	37
Escitalopram Oxalate	Escitalopram Oxalate	153	34
Hydrochlorothiazide	Hydrochlorothiazide	151	39
Tamsulosin Hcl	Tamsulosin Hcl	149	39
Losartan Potassium	Losartan Potassium	144	37
Sertraline Hcl	Sertraline Hcl	140	27
Furosemide	Furosemide	134	31
Lorazepam	Lorazepam	134	42
Gabapentin	Gabapentin	123	28
Eliquis	Apixaban	116	23
Allopurinol	Allopurinol	109	26
Atenolol	Atenolol	108	21
Tramadol Hcl	Tramadol Hcl	103	24
Rosuvastatin Calcium	Rosuvastatin Calcium	92	26
Duloxetine Hcl	Duloxetine Hcl	89	15
Albuterol Sulfate Hfa	Albuterol Sulfate	87	33
Bupropion Xl	Bupropion Hcl	84	11
Montelukast Sodium	Montelukast Sodium	82	22
Pravastatin Sodium	Pravastatin Sodium	82	21
Zolpidem Tartrate	Zolpidem Tartrate	82	20
Potassium Chloride	Potassium Chloride	80	21
Ibandronate Sodium	Ibandronate Sodium	78	14
Alprazolam	Alprazolam	73	26
Donepezil Hcl	Donepezil Hcl	73	13
Clopidogrel	Clopidogrel Bisulfate	72	20
Famotidine	Famotidine	69	14
Clonazepam	Clonazepam	68	12
Torsemide	Torsemide	65	13
Xarelto	Rivaroxaban	65	suppressed
Finasteride	Finasteride	63	18
Meclizine Hcl	Meclizine Hcl	61	14
Synthroid	Levothyroxine Sodium	61	18
Fluticasone Propionate	Fluticasone Propionate	60	18
Prednisone	Prednisone	50	39
Januvia	Sitagliptin Phosphate	49	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Carvedilol	Carvedilol	45	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	15
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Methocarbamol	Methocarbamol	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Spironolactone	Spironolactone	40	suppressed
Irbesartan	Irbesartan	37	11
Meloxicam	Meloxicam	37	12
Trazodone Hcl	Trazodone Hcl	37	suppressed
Fenofibrate	Fenofibrate	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Diazepam	Diazepam	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	11
Mirtazapine	Mirtazapine	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Valsartan	Valsartan	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Nystatin	Nystatin	21	11
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Azithromycin	Azithromycin	19	15
Benazepril Hcl	Benazepril Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Glipizide	Glipizide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Verapamil Er	Verapamil Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Ozempic	Semaglutide	16	suppressed
Temazepam	Temazepam	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Buspirone Hcl	Buspirone Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Naproxen	Naproxen	12	suppressed
Nyamyc	Nystatin	12	suppressed
Ramipril	Ramipril	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Econazole Nitrate	Econazole Nitrate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Primidone	Primidone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error